Other
Surgical
0
Pipeline Programs↗
15
Active Trials↗
6
Companies Involved↗
Surgical is an early-stage landscape with 0 programs across 6 companies. The most active players are Johnson & Johnson Taiwan Ltd, Tafalgie Therapeutics, Pacira Pharmaceuticals, Inc.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
79
clinical trials
Completed37 · 47%
Terminated11 · 14%
Unknown status9 · 11%
Recruiting9 · 11%
Withdrawn7 · 9%
Not yet recruiting2 · 3%
Other4 · 5%
Clinical Trials
Trial Activity
79 trials
Surgical Pembro +/- Olaparib w TMZ for rGBM
Recruiting·—·Phase 2·NCT05463848·78 enrolled
Oral Health Outcomes With Amphion Mouthwash as an Adjunct to Non-Surgical Periodontal Therapy
Not yet recruiting·SSecond Affiliated Hospital, School of Medicine, Zhejiang University·Phase 4·NCT07402694·60 enrolled
Minimally Invasive Non-surgical Therapy With or Without Injectable Bone Putty
Not yet recruiting·—·Phase 3·NCT06553222·30 enrolled
Exparel vs. Marcaine ESP Block for Post-cardiac Surgical Pain
Enrolling by invitation·RRutgers, The State University of New Jersey·Phase 2/3·NCT06077422·150 enrolled
Page 1 of 6
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)